Blue Jet Healthcare Limited
NSE: BLUEJETINE0KBH01020·HealthcareSmallcap 250·www.bluejethealthcare.com ↗·Mcap ₹11,075 Cr·Listed 2023
₹570.65▼ ₹2.80  (−0.49%)
52W: ₹325 – ₹693 · Vol: 2.5L shares · Close 25 Sept
Set Alert

Quarterly results

standalone · as filed with NSE · Q1 FY27 back to Q2 FY24
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24
Revenue from operations293235192165355340318208163184167181
Other income15.222.913.224.38.312.213.212.18.78.86.88.2
Total expenses202170152121240205199143122139120125
EBITDA98.171.346.954.912114012469.544.353.154.662.6
EBITDA margin33.5%30.4%24.4%33.2%34.1%41.1%39.0%33.4%27.2%28.8%32.7%34.5%
Finance costs0.70.60.34.60.70000000
Depreciation6.76.565.95.74.94.74.63.57.77.96.5
Profit before tax10687.153.868.712314713276.949.554.243.764.3
Tax27.722.813.616.631.737.133.518.611.714.511.616.5
Net profit78.364.340.252.191.21109958.337.839.532.147.9
Net margin26.7%27.4%20.9%31.5%25.7%32.3%31.1%28.0%23.2%21.5%19.3%26.4%
EPS (₹)4.513.712.323.015.266.355.713.362.182.291.852.76
Net profit YoY−14.2%−41.6%−59.4%−10.6%+141.3%+178.8%+208.3%+21.9%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24
Revenue from operations9471,030712
Other income68.746.328.9
Total expenses683670511
EBITDA294378229
EBITDA margin31.0%36.7%32.2%
Finance costs6.20.10.2
Depreciation2417.828.1
Profit before tax333406220
Tax84.710156.3
Net profit248305164
Net margin26.2%29.6%23.0%
EPS (₹)14.2917.599.44
Net profit YoY−18.8%+86.4%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24
Operating cash flow33445.8241
Investing cash flow−276−35.2−264
Financing cash flow−30.7−18.6−2
Capital expenditure079.9173
Free cash flow (CFO − capex)334−34.168.4

Net profit trend

annual, ₹ crore
FY24
₹164
FY25
₹305+86%
FY26
₹248−19%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Standalone3 Aug 2026PDF on NSE XBRL
Q4 FY26Standalone · audited25 May 2026PDF on NSE XBRL
Q3 FY26Standalone13 Feb 2026 PDF XBRL
Q2 FY26Standalone4 Nov 2025 PDF XBRL
Q1 FY26Standalone22 Jul 2025 PDF XBRL
Q4 FY25Standalone · audited14 May 2025PDF on NSE XBRL
Q3 FY25Standalone29 Jan 2025PDF on NSE XBRL
Q2 FY25Standalone29 Oct 2024PDF on NSE XBRL
Q1 FY25Standalone6 Aug 2024PDF on NSE XBRL
Q4 FY24Standalone · audited26 May 2024PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 37.9×42.1×
P/B5Y avg 8.76×7.28×
ROEFY26, on average equity19.9%
Net margin26.2%
Debt / equity0.00×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹13.54
Market cap₹9,899 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
7.28×
vs 5-point avg 8.76× (−17%)
4.17× low8.76× avg13.55× high
History points are balance-sheet dates (2024 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹1,641 Cr+16%
Net worth₹1,360 Cr+20%
Total borrowings₹0 Cr
Cash & bank balances₹61 Cr+85%
Investments₹252 Cr+35%
Inventories₹187 Cr−29%
Trade receivables₹339 Cr−3%
Trade payables₹57 Cr−36%
Change vs the same date a year earlier.
Shareholding 9 Jul 2026
%Jul 26Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter73.1579.8179.8179.8179.8186.0086.0086.0086.0086.0086.0086.00
FII0.620.400.881.141.821.972.291.102.182.022.012.93
DII9.124.654.514.653.630.941.332.021.742.143.033.70
of which MF5.181.721.622.011.770.50––––––
Retail10.0911.0210.609.919.798.037.286.305.905.795.374.73
Other public7.024.124.204.494.953.063.104.584.184.053.592.64
78,927 shareholders · NSE shareholding pattern filings.